Rupert Dixon

Rupert Dixon has extensive work experience in the pharmaceutical industry. Currently, they hold the position of Vice President and Development Lead for Early Solutions at UCB, where they have been since September 2021. Rupert is also a Visiting Research Fellow at King's College London since September 2021. Previously, Rupert held the role of Vice President of Strategic Drug Development at IQVIA from January 2016 to September 2021. Rupert also worked at AstraZeneca as a Director of Clinical Development from 2007 to 2015 and as a Clinical Program Leader from 2004 to 2007. Additionally, they have worked as a Project Manager at Mitsubishi Tanabe Pharma Europe Limited from 2001 to 2004, a Clinical Project Leader at Eisai from 1999 to 2001, and a Senior Regional Clinical Associate at Wyeth Ayerst Laboratories from 1997 to 1999. Before entering the industry, they were a Royal Society / NATO Post-doctoral Fellow at the University of Padova from 1996 to 1997.

Rupert Dixon holds a Doctor of Philosophy (PhD) in Neuroscience from Newcastle University, which they obtained from 1993 to 1996. Prior to that, they completed their Bachelor of Science (BSc) in Zoology at Newcastle University from 1990 to 1993. Rupert Dixon attended Nottingham High School from 1982 to 1989. In addition to their degrees, they have obtained certifications in "Leading and Managing Globally" from Yale School of Management, "Chartered Scientist" from the Institute of Biomedical Science, and "Managing Successful Programs Practitioner" from AXELOS Global Best Practice. The specific years of obtaining these certifications are not mentioned.